139 related articles for article (PubMed ID: 14633729)
1. Potent inhibitor of N-myristoylation: a novel molecular target for cancer.
Shrivastav A; Pasha MK; Selvakumar P; Gowda S; Olson DJ; Ross AR; Dimmock JR; Sharma RK
Cancer Res; 2003 Nov; 63(22):7975-8. PubMed ID: 14633729
[TBL] [Abstract][Full Text] [Related]
2. Regulation of N-myristoyltransferase by novel inhibitor proteins.
Shrivastav A; Selvakumar P; Bajaj G; Lu Y; Dimmock JR; Sharma RK
Cell Biochem Biophys; 2005; 43(1):189-202. PubMed ID: 16043893
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
4. Myristoyl-CoA:protein N-myristoyltransferase: a novel molecular approach for cancer therapy (Review).
Selvakumar P; Pasha MK; Ashakumary L; Dimmock JR; Sharma RK
Int J Mol Med; 2002 Oct; 10(4):493-500. PubMed ID: 12239600
[TBL] [Abstract][Full Text] [Related]
5. Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.
Sikorski JA; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Nagarajan S; Mehta PP; Wade AC; Kishore NS; Bryant ML; Getman DP; McWherter CA; Gordon JI
Biopolymers; 1997; 43(1):43-71. PubMed ID: 9174411
[TBL] [Abstract][Full Text] [Related]
6. Effects of L-histidine and its structural analogues on human N-myristoyltransferase activity and importance of EEVEH amino acid sequence for enzyme activity.
Raju RV; Datla RS; Warrington RC; Sharma RK
Biochemistry; 1998 Oct; 37(42):14928-36. PubMed ID: 9778369
[TBL] [Abstract][Full Text] [Related]
7. Potential role of N-myristoyltransferase in cancer.
Selvakumar P; Lakshmikuttyamma A; Shrivastav A; Das SB; Dimmock JR; Sharma RK
Prog Lipid Res; 2007 Jan; 46(1):1-36. PubMed ID: 16846646
[TBL] [Abstract][Full Text] [Related]
8. N-terminal N-myristoylation of proteins: prediction of substrate proteins from amino acid sequence.
Maurer-Stroh S; Eisenhaber B; Eisenhaber F
J Mol Biol; 2002 Apr; 317(4):541-57. PubMed ID: 11955008
[TBL] [Abstract][Full Text] [Related]
9. Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-based inhibitors of human N-myristoyltransferase-1.
French KJ; Zhuang Y; Schrecengost RS; Copper JE; Xia Z; Smith CD
J Pharmacol Exp Ther; 2004 Apr; 309(1):340-7. PubMed ID: 14724220
[TBL] [Abstract][Full Text] [Related]
10. N-myristoyltransferase inhibitor protein is homologous to heat shock cognate protein 70.
Selvakumar P; Lakshmikuttyamma A; Pasha MK; King MJ; Olson DJ; Mori S; Ross AR; Hayashi K; Dimmock JR; Sharma RK
J Cell Biochem; 2004 Jun; 92(3):573-8. PubMed ID: 15156568
[TBL] [Abstract][Full Text] [Related]
11. N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences.
Maurer-Stroh S; Eisenhaber B; Eisenhaber F
J Mol Biol; 2002 Apr; 317(4):523-40. PubMed ID: 11955007
[TBL] [Abstract][Full Text] [Related]
12. N-Myristoyltransferase overexpression in human colorectal adenocarcinomas.
Raju RV; Moyana TN; Sharma RK
Exp Cell Res; 1997 Aug; 235(1):145-54. PubMed ID: 9281363
[TBL] [Abstract][Full Text] [Related]
13. Myristoyltransferase and calcineurin: novel molecular therapeutic target for epilepsy.
Lakshmikuttyamma A; Selvakumar P; Tuchek J; Sharma RK
Prog Neurobiol; 2008 Jan; 84(1):77-84. PubMed ID: 17997006
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of human N-myristoyltransferase by N-myristoylated SRC family tyrosine kinase members.
Rajala RV; Datla RS; Carlsen SA; Anderson DH; Qi Z; Wang JH; Sharma RK
Biochem Biophys Res Commun; 2001 Oct; 288(1):233-9. PubMed ID: 11594778
[TBL] [Abstract][Full Text] [Related]
15. Expression of N-myristoyltransferase inhibitor protein and its relationship to c-Src levels in human colon cancer cell lines.
Rajala RV; Dehm S; Bi X; Bonham K; Sharma RK
Biochem Biophys Res Commun; 2000 Jul; 273(3):1116-20. PubMed ID: 10891381
[TBL] [Abstract][Full Text] [Related]
16. Potential role of N-myristoyltransferase in pathogenic conditions.
Sharma RK
Can J Physiol Pharmacol; 2004 Oct; 82(10):849-59. PubMed ID: 15573145
[TBL] [Abstract][Full Text] [Related]
17. Elevated N-myristoyltransferase activity and expression in oral squamous cell carcinoma.
Shrivastav A; Sharma AR; Bajaj G; Charavaryamath C; Ezzat W; Spafford P; Gore-Hickman R; Singh B; Copete MA; Sharma RK
Oncol Rep; 2007 Jul; 18(1):93-7. PubMed ID: 17549352
[TBL] [Abstract][Full Text] [Related]
18. [Evolutionary trace analysis of N-myristoyltransferase family].
Sheng CQ; Zhu J; Zhang WN; Xu H; Miao ZY; Yao JZ; Zhang M
Yao Xue Xue Bao; 2007 Feb; 42(2):157-65. PubMed ID: 17518043
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of bovine brain N-myristoyltransferase(s) by a cytosolic activator.
King MJ; Sharma RK
Biochem Biophys Res Commun; 1995 Jul; 212(2):580-8. PubMed ID: 7626073
[TBL] [Abstract][Full Text] [Related]
20. Expression of methionine aminopeptidase 2, N-myristoyltransferase, and N-myristoyltransferase inhibitor protein 71 in HT29.
Selvakumar P; Lakshmikuttyamma A; Lawman Z; Bonham K; Dimmock JR; Sharma RK
Biochem Biophys Res Commun; 2004 Sep; 322(3):1012-7. PubMed ID: 15336565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
